XML 17 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 29, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents, including restricted cash of $0.3 in 2024 and $0.6 in 2023 $ 695.0 $ 545.4
Accounts receivable, less allowance for credit losses of $25.8 in 2024 and $12.7 in 2023 919.8 1,029.3
Inventories 274.2 332.0
Prepaid expenses and other current assets 353.5 416.9
Total current assets 2,242.5 2,323.6
Property, plant and equipment, net 302.6 334.3
Goodwill 2,278.2 2,279.2
Other intangibles, net 518.4 587.5
Other 998.6 1,016.3
Total assets 6,340.3 6,540.9
Current liabilities    
Current portion of long-term debt 0.0 500.0
Accounts payable 341.5 340.6
Accrued liabilities 1,059.8 1,215.8
Total current liabilities 1,401.3 2,056.4
Long-term debt 3,380.8 2,965.8
Other liabilities 373.2 431.7
Total liabilities 5,155.3 5,453.9
Commitments and contingencies (Note 20)
Shareholders’ equity    
Preference stock of $2.50 par value. Authorized 5,000,000 shares; none issued 0.0 0.0
Common stock of $0.50 par value. Authorized 600,000,000 shares; issued 220,286,736 shares as of 2024 and 2023 110.1 110.1
Additional paid-in capital 2,632.2 2,590.6
Retained earnings 2,274.2 2,188.4
Accumulated other comprehensive loss (246.4) (201.5)
Treasury stock, at cost, 80,758,045 shares in 2024 and 81,498,181 shares in 2023 (3,612.5) (3,625.7)
Noncontrolling interests 27.4 25.1
Total shareholders’ equity 1,185.0 1,087.0
Total liabilities, noncontrolling interests and shareholders’ equity $ 6,340.3 $ 6,540.9